Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.
02096.HK stock price ended at $12.28 on Jueves, after dropping 3.08%
On the latest trading day Feb 12, 2026, the stock price of 02096.HK fell by 3.08%, dropping from $12.56 to $12.28. During the session, the stock saw a volatility of 3.70%, with prices oscillating between a daily low of $12.17 and a high of $12.62. On the latest trading day, the trading volume for 02096.HK rose by 316.5K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 4.6M shares were traded, with a market value of approximately $31.8B.
Señales Técnicas de 02096.HK
Resumen de Señales Técnicas
Señales de compra 3
Señales Neutras 1
Señales de venta 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
02096.HK actualmente presenta 3 señales de compra y 3 señales de venta. La acción ha estado en una tendencia bajista desde 12:00 AM, con un cambio total en el precio de -3.08% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Neutral para el mediano plazo.
Señales alcistas/bajistas para 02096.HK
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para 02096.HK. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.